| Intrapleural use of tissue plasminogen activator and DNase in pleural infection NM Rahman, NA Maskell, A West, R Teoh, A Arnold, C Mackinlay, ... New England Journal of Medicine 365 (6), 518-526, 2011 | 867 | 2011 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 589 | 2021 |
| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 571 | 2016 |
| Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers M Deakin, J Elder, C Hendrickkse, D Peckham, D Leopard, DA Bell, ... Oxford University Press 17 (4), 881-884, 1996 | 432 | 1996 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 362 | 2022 |
| European cystic fibrosis society standards of care: framework for the cystic fibrosis centre S Conway, IM Balfour-Lynn, K De Rijcke, P Drevinek, J Foweraker, ... Journal of Cystic Fibrosis 13, S3-S22, 2014 | 288 | 2014 |
| Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers T Daniels, L Goodacre, C Sutton, K Pollard, S Conway, D Peckham Chest 140 (2), 425-432, 2011 | 257 | 2011 |
| Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review P Wood, S Stanworth, J Burton, A Jones, DG Peckham, T Green, C Hyde, ... Clinical & Experimental Immunology 149 (3), 410-423, 2007 | 255 | 2007 |
| Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis J Li, K Coulthard, R Milne, RL Nation, S Conway, D Peckham, ... Journal of Antimicrobial Chemotherapy 52 (6), 987-992, 2003 | 226 | 2003 |
| Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis SP Conway, KG Brownlee, M Denton, DG Peckham American Journal of Respiratory Medicine 2, 321-332, 2003 | 169 | 2003 |
| Neurodegenerative disease and the NLRP3 inflammasome JA Holbrook, HH Jarosz-Griffiths, E Caseley, S Lara-Reyna, JA Poulter, ... Frontiers in pharmacology 12, 643254, 2021 | 153 | 2021 |
| Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis P Whitaker, X Meng, SN Lavergne, S El-Ghaiesh, M Monshi, C Earnshaw, ... The Journal of Immunology 187 (1), 200-211, 2011 | 148 | 2011 |
| Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis DR Baldwin, AL Hill, DG Peckham, AJ Knox Respiratory medicine 88 (1), 49-53, 1994 | 118 | 1994 |
| Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis S El-Ghaiesh, MM Monshi, P Whitaker, R Jenkins, X Meng, J Farrell, ... Journal of Pharmacology and Experimental Therapeutics 341 (3), 597-610, 2012 | 116 | 2012 |
| Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week … S Sutharsan, EF McKone, DG Downey, J Duckers, G MacGregor, E Tullis, ... The Lancet Respiratory Medicine 10 (3), 267-277, 2022 | 111 | 2022 |
| The global impact of SARS-CoV-2 in 181 people with cystic fibrosis E McClenaghan, R Cosgriff, K Brownlee, S Ahern, PR Burgel, CA Byrnes, ... Journal of cystic fibrosis 19 (6), 868-871, 2020 | 111 | 2020 |
| The benefits of 3D modelling and animation in medical teaching T Vernon, D Peckham Journal of Audiovisual media in Medicine 25 (4), 142-148, 2002 | 110 | 2002 |
| Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis HH Jarosz-Griffiths, T Scambler, CH Wong, S Lara-Reyna, J Holbrook, ... Elife 9, e54556, 2020 | 106 | 2020 |
| ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis T Scambler, HH Jarosz-Griffiths, S Lara-Reyna, S Pathak, C Wong, ... Elife 8, e49248, 2019 | 101 | 2019 |
| Alcaligenes infection in cystic fibrosis K Tan, SP Conway, KG Brownlee, C Etherington, DG Peckham Pediatric pulmonology 34 (2), 101-104, 2002 | 98 | 2002 |
Dean NaisbittUniversity of LiverpoolCorreu electrònic verificat a liv.ac.uk
